Esther12
Senior Member (Voting Rights)
"The Improving Access to Psychological Therapies (IAPT) Pathway for People with Long-term Physical Health Conditions and Medically Unexplained Symptoms. Full implementation guidance"
https://www.rcpsych.ac.uk/docs/defa...implementation-guidance.pdf?sfvrsn=de824ea4_2
This looks as bad as you'd expect considering people like Rona Moss-Morris and Michael Sharpe are part of their expert reference group.
Looks like this is likely to have a big impact on patients, and lead to the creation of a lot more professional with a vested interest in protecting biopsychosocial approaches to MUS.
Their MUS definition:
I'm sure I was recently reading someone saying that they found a lot of figures like these were spun:
37
Burton C, McGorm K, Richardson G,
Weller D, Sharpe M. Healthcare costs
incurred by patients repeatedly referred to
secondary medical care with medically
unexplained symptoms: a cost of illness
study. Journal of Psychosomatic
Research. 2012;72:242-47.
40
Konnopka A, Kaufmann C, König H,
Heider D, Wild B, Szecsenyi J, et al.
Association of costs with somatic
symptom severity in patients with
medically unexplained symptoms. Journal
of Psychosomatic Research. 2013:370-75
41
Nimnuan T, Hotopf M, Wessely S.
Medically unexplained symptoms: an
epidemiological study in seven specialties.
Journal of Psychosomatic Research.
2001;51:361-67
They've already been adding staff for this, and expect to need another 4,500:
47
Roth A, Pilling S. A Competence
Framework for Psychological Interventions
with People with Persistent Physical
Health Conditions. London: UCL; 2016.
Figure 5 is on page 21 and does not inspire confidence. It's things like this as 'Core Knowledge': "Knowledge of a generic model of MUS".
Shows how important NICE have been for promoting this stuff:
It's hard to remember which quack-ridden expert advisory group is which with the MUS stuff:
So what's recommended for CFS and MUS, and why?:
There's no mention of the CFS guidelines being updated although they say "Note: NICE depression guidance currently being updated."
https://www.rcpsych.ac.uk/docs/defa...implementation-guidance.pdf?sfvrsn=de824ea4_2
This looks as bad as you'd expect considering people like Rona Moss-Morris and Michael Sharpe are part of their expert reference group.
Looks like this is likely to have a big impact on patients, and lead to the creation of a lot more professional with a vested interest in protecting biopsychosocial approaches to MUS.
Their MUS definition:
Persistent and distressing bodily symptoms characterised by functional disability that cannot
wholly be explained by a known physical pathological cause; psychological processes are often involved in the presentation of MUS. Examples include: chronic fatigue syndrome, chronic pain and irritable bowel syndrome.
I'm sure I was recently reading someone saying that they found a lot of figures like these were spun:
people with MUS account for up to 45% of primary care consultations [37, 40] and up to 66% of outpatient clinics. [41]
37
Burton C, McGorm K, Richardson G,
Weller D, Sharpe M. Healthcare costs
incurred by patients repeatedly referred to
secondary medical care with medically
unexplained symptoms: a cost of illness
study. Journal of Psychosomatic
Research. 2012;72:242-47.
40
Konnopka A, Kaufmann C, König H,
Heider D, Wild B, Szecsenyi J, et al.
Association of costs with somatic
symptom severity in patients with
medically unexplained symptoms. Journal
of Psychosomatic Research. 2013:370-75
41
Nimnuan T, Hotopf M, Wessely S.
Medically unexplained symptoms: an
epidemiological study in seven specialties.
Journal of Psychosomatic Research.
2001;51:361-67
They've already been adding staff for this, and expect to need another 4,500:
It is expected that 4,500 more clinicians will be
required to support the expansion of IAPT-LTC services.
The key skills required to deliver psychological therapies effectively for people with LTCs and MUS are outlined in the Competence Framework for Psychological Interventions with People with Persistent Physical Health Conditions 47 (see Figure 5 ) .
47
Roth A, Pilling S. A Competence
Framework for Psychological Interventions
with People with Persistent Physical
Health Conditions. London: UCL; 2016.
Figure 5 is on page 21 and does not inspire confidence. It's things like this as 'Core Knowledge': "Knowledge of a generic model of MUS".
Shows how important NICE have been for promoting this stuff:
4.1
Existing NICE guidance
A wide range of NICE guidance is available for the treatment of depression and anxiety disorders in the general population, for LTCs and for specific diagnostic groups of MUS, including irritable bowel syndrome and chronic fatigue syndrome.
It's hard to remember which quack-ridden expert advisory group is which with the MUS stuff:
4.1.1 Recommendations of an expert advisory group
With this in mind an expert advisory group was convened by NHS England c to review d existing NICE guidance for the use of psychological therapies for the treatment of depression and anxiety disorders in the context of LTCs and for the treatment of MUS
c
NHS England IAPT Education and Training Group
(ETG).
d
It should be noted that ‘review’ in this context does
not mean appraising the guidance with a view to
updating it because of potential new evidence,
but rather assessing whether psychological
therapies recommended for people with
depression and anxiety disorders are suitable for
people who also have LTCs and who have
MUS.
So what's recommended for CFS and MUS, and why?:
Chronic fatigue
syndrome
Graded exercise therapy, CBT
*
NICE guideline:
CG53
MUS not
otherwise
specified
CBT
*
Informal consensus
of the ETG
There's no mention of the CFS guidelines being updated although they say "Note: NICE depression guidance currently being updated."